Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T C Hamilton

Showing results (91-100 of 186) with videos related to

Pageof 19
Sort By:
Cancer Research|August 15, 1993
Variable baseline gamma-glutamylcysteine synthetase messenger RNA expression in peripheral mononuclear cells of cancer patients, and its induction by buthionine sulfoximine treatmentK Yao, A K Godwin, R F Ozols, et al.
European Journal of Pharmacology|August 2, 1988
Comparative effects of K+ channel blockade on the vasorelaxant activity of cromakalim, pinacidil and nicorandilC Wilson, M C Coldwell, D R Howlett, et al.
Seminars in Oncology|June 20, 1998
The biology of ovarian cancerN Auersperg, M I Edelson, S C Mok, et al.
Cancer Research|March 1, 1997
Increased platinum-DNA damage tolerance is associated with cisplatin resistance and cross-resistance to various chemotherapeutic agents in unrelated human ovarian cancer cell linesS W Johnson, P B Laub, J S Beesley, et al.
Science (New York, N.Y.)|June 1, 1984
Reversal of adriamycin resistance by verapamil in human ovarian cancerA M Rogan, T C Hamilton, R C Young, et al.
Journal of Medicinal Chemistry|September 1, 1984
Synthesis and antihypertensive activity of 6,7-disubstituted trans-4-amino-3,4-dihydro-2,2-dimethyl-2H-1-benzopyran-3-olsJ M Evans, C S Fake, T C Hamilton, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1988
Modulation of induced resistance to adriamycin in two human breast cancer cell lines with tamoxifen or perhexiline maleateB J Foster, K R Grotzinger, W M McKoy, et al.
Biochemical Pharmacology|December 15, 1988
Enhanced DNA repair and resistance to cisplatin in human ovarian cancerG M Lai, R F Ozols, J F Smyth, et al.
The Journal of Biological Chemistry|June 13, 2001
Disassociation of MAPK activation and c-Fos expression in F9 embryonic carcinoma cells following retinoic acid-induced endoderm differentiationE R Smith, J L Smedberg, M E Rula, et al.
Clinical Chemistry|October 1, 1982
Clinical evaluation of immunochemical assay of lactate dehydrogenase isoenzyme 1 in early detection of acute myocardial infarctionT Y Wang, J H Godfrey, L G Graham, et al.
Pageof 19

Showing results (91-100 of 186) with videos related to

Sort By:
Pageof 19
Cancer Research|August 15, 1993
Variable baseline gamma-glutamylcysteine synthetase messenger RNA expression in peripheral mononuclear cells of cancer patients, and its induction by buthionine sulfoximine treatmentK Yao, A K Godwin, R F Ozols, et al.
European Journal of Pharmacology|August 2, 1988
Comparative effects of K+ channel blockade on the vasorelaxant activity of cromakalim, pinacidil and nicorandilC Wilson, M C Coldwell, D R Howlett, et al.
Seminars in Oncology|June 20, 1998
The biology of ovarian cancerN Auersperg, M I Edelson, S C Mok, et al.
Cancer Research|March 1, 1997
Increased platinum-DNA damage tolerance is associated with cisplatin resistance and cross-resistance to various chemotherapeutic agents in unrelated human ovarian cancer cell linesS W Johnson, P B Laub, J S Beesley, et al.
Science (New York, N.Y.)|June 1, 1984
Reversal of adriamycin resistance by verapamil in human ovarian cancerA M Rogan, T C Hamilton, R C Young, et al.
Journal of Medicinal Chemistry|September 1, 1984
Synthesis and antihypertensive activity of 6,7-disubstituted trans-4-amino-3,4-dihydro-2,2-dimethyl-2H-1-benzopyran-3-olsJ M Evans, C S Fake, T C Hamilton, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1988
Modulation of induced resistance to adriamycin in two human breast cancer cell lines with tamoxifen or perhexiline maleateB J Foster, K R Grotzinger, W M McKoy, et al.
Biochemical Pharmacology|December 15, 1988
Enhanced DNA repair and resistance to cisplatin in human ovarian cancerG M Lai, R F Ozols, J F Smyth, et al.
The Journal of Biological Chemistry|June 13, 2001
Disassociation of MAPK activation and c-Fos expression in F9 embryonic carcinoma cells following retinoic acid-induced endoderm differentiationE R Smith, J L Smedberg, M E Rula, et al.
Clinical Chemistry|October 1, 1982
Clinical evaluation of immunochemical assay of lactate dehydrogenase isoenzyme 1 in early detection of acute myocardial infarctionT Y Wang, J H Godfrey, L G Graham, et al.
Pageof 19